This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 2005-0474OCv1 35/3/337    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fulkerson, P. C. Articles by Rothenberg, M. E. Search for Related Content PubMed PubMed Citation Articles by Fulkerson, P. C. Articles by Rothenberg, M. E.

Persistent Effects Induced by IL-13 in the Lung

Departments of Molecular Genetics, Biochemistry & Microbiology, and Cellular and Molecular Biology; and Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio

Correspondence and requests for reprints should be addressed to Marc E. Rothenburg, Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. E-mail: Rothenberg{at}cchmc.org

IL-13 overexpression in the lung induces inflammatory and remodeling responses that are prominent features of asthma. Whereas most studies have concentrated on the development of IL-13–induced disease, far fewer studies have focused on the reversibility of IL-13–induced pathologies. This is particularly important because current asthma therapy appears to be poor at reversing lung remodeling. In this manuscript, we used an externally regulatable transgenic system that targets expression of IL-13 to the lung with the aim of characterizing the reversibility process. After 4 wk of doxycycline (dox) exposure, IL-13 expression resulted in mixed inflammatory cell infiltration, mucus cell metaplasia, lung fibrosis, and airspace enlargement (emphysema). After withdrawal of dox, IL-13 protein levels were profoundly reduced by 7 d and below baseline by 14 d. During this time frame, the level of lung eosinophils returned to near normal, whereas macrophages, lymphocytes, and neutrophils remained markedly elevated. IL-13–induced mucus cell metaplasia significantly decreased (91%) 3 wk after withdrawal of dox, showing strong correlation with reduced eosinophil levels. In contrast, IL-13–induced lung fibrosis did not significantly decline 4 wk after dox withdrawal. Importantly, IL-13–induced emphysema persisted, but modestly declined 4 wk after dox. Examination of transcript expression profiles identified a subset of genes that remained increased weeks after transgene expression was no longer detected. Notably, numerous IL-13–induced cytokines and enzymes were reversible (IL-6 and cathepsins), whereas others were sustained (CCL6 and chitinases) after IL-13 withdrawal, respectively. Thus, several hallmark features of IL-13–induced lung pathology persist and are dissociated from eosinophilia after IL-13 overexpression ceases.

Key Words: asthma • cytokines • eosinophils • inflammation • lung

This article has been cited by other articles:

				J. Zhao, B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, H. Hu, J. B. Trudeau, V. O'Donnell, and S. E. Wenzel Interleukin-13-induced MUC5AC Is Regulated by 15-Lipoxygenase 1 Pathway in Human Bronchial Epithelial Cells Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 782 - 790. [Abstract] [Full Text] [PDF]

				T. X. Lu, A. Munitz, and M. E. Rothenberg MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression J. Immunol., April 15, 2009; 182(8): 4994 - 5002. [Abstract] [Full Text] [PDF]

				T. A. Doherty, P. Soroosh, D. H. Broide, and M. Croft CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L229 - L235. [Abstract] [Full Text] [PDF]

				M. Gilchrist, W. R. Henderson Jr., A. E. Clark, R. M. Simmons, X. Ye, K. D. Smith, and A. Aderem Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation J. Exp. Med., September 29, 2008; 205(10): 2349 - 2357. [Abstract] [Full Text] [PDF]

				A. G. Therien, V. Bernier, S. Weicker, P. Tawa, J.-P. Falgueyret, M.-C. Mathieu, J. Honsberger, V. Pomerleau, A. Robichaud, R. Stocco, et al. Adenovirus IL-13-Induced Airway Disease in Mice: A Corticosteroid-Resistant Model of Severe Asthma Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 26 - 35. [Abstract] [Full Text] [PDF]

				A. Munitz, M. L. McBride, J. S. Bernstein, and M. E. Rothenberg A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils Blood, June 15, 2008; 111(12): 5694 - 5703. [Abstract] [Full Text] [PDF]

				A. Munitz, E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg Distinct roles for IL-13 and IL-4 via IL-13 receptor {alpha}1 and the type II IL-4 receptor in asthma pathogenesis PNAS, May 20, 2008; 105(20): 7240 - 7245. [Abstract] [Full Text] [PDF]

				B. F. Dickey Exoskeletons and Exhalation N. Engl. J. Med., November 15, 2007; 357(20): 2082 - 2084. [Full Text] [PDF]

				Y. Ma, K. T. HayGlass, A. B. Becker, Y. Fan, X. Yang, S. Basu, G. Srinivasan, F. E. R. Simons, A. J. Halayko, and Z. Peng Novel Recombinant Interleukin-13 Peptide-based Vaccine Reduces Airway Allergic Inflammatory Responses in Mice Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 439 - 445. [Abstract] [Full Text] [PDF]

				I. H. Heijink, P. Marcel Kies, A. J. M. van Oosterhout, D. S. Postma, H. F. Kauffman, and E. Vellenga Der p, IL-4, and TGF-beta Cooperatively Induce EGFR-Dependent TARC Expression in Airway Epithelium Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 351 - 359. [Abstract] [Full Text] [PDF]

				P. C. Fulkerson, C. A. Fischetti, and M. E. Rothenberg Eosinophils and CCR3 Regulate Interleukin-13 Transgene-Induced Pulmonary Remodeling Am. J. Pathol., December 1, 2006; 169(6): 2117 - 2126. [Abstract] [Full Text] [PDF]

				P. C. Fulkerson, C. A. Fischetti, M. L. McBride, L. M. Hassman, S. P. Hogan, and M. E. Rothenberg A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation PNAS, October 31, 2006; 103(44): 16418 - 16423. [Abstract] [Full Text] [PDF]